adenadel

57 ms·

571.
A possible declining trend in worldwide innovation [pdf](81.47.175.201)
2 points by adenadel 11y ago|0 comments
572.
by adenadel 11y ago
As a bioinformatician, I completely agree with you. My question is, which contributes more to the field? A specialist enabled by code, or a coder who has learned something of a second field?
573.
by adenadel 11y ago
I agree that "publish or perish" is not a good model for research. What are alternative models that are potentially viable?
574.
by adenadel 11y ago
Finance, statistics, biology, mathematics, energy, manufacturing, education, fitness... (not trying to be condescending here) I think software could be a great pairing with many other areas. I'm not sure if it's better to have so
575.
Tornado warning in San Diego(google.org)
1 points by adenadel 11y ago|0 comments
576.
by adenadel 11y ago
I think you're generalizing what current software venture capital looks like to all of VC. Historically the types of companies discussed in the article did get funding from VCs (Fairchild Semiconductor, Intel, Genentech, etc.) Maybe VC
577.
Editas Medicine Files for CRISPR Technology's First IPO(bio-itworld.com)
3 points by adenadel 11y ago|0 comments
578.
by adenadel 11y ago
The thing is... fees to publishers don't contribute to funding science.
579.
by adenadel 11y ago
Most readers get access through a library or their place of work (usually those involved with scientific industries). I don't know if I've ever heard from anyone paying those prices for a single article. If you went to a 4 year co
580.
Craig Venter describes work that Human Longevity Institute is doing [video](youtube.com)
4 points by adenadel 11y ago|0 comments
581.
by adenadel 11y ago
You're right that having a graduate degree isn't a guarantee of having a "super-brain", but having a graduate or professional degree is probably a good proxy for the type of socioeconomic inferences they are trying to ma
582.
by adenadel 11y ago
It's important to be aware of the absolute risk even when the relative increase is 87%. In this case the risks are always below 1.5%. I haven't read the paper, but the presence of depression (rather than the SSRIs) could also be a
583.
by adenadel 11y ago
They have a lot of great television, but the film selection always seems limited.
584.
by adenadel 11y ago
They aren't laying off the entire workforce, only 10%. The 6300 and 100K per employee figures are accurate.
585.
by adenadel 11y ago
According to Crunchbase this is the 17th round of funding. That seems insane to me.
586.
by adenadel 11y ago
It's incredible that he thinks that sort of labeling would be ok. "I'm selling you this drug, but the FDA hasn't agreed that it is effective." This is just not the way things are done.
587.
Illumina Invests in Four Startups Through Accelerator Program(genomeweb.com)
5 points by adenadel 11y ago|0 comments
588.
by adenadel 11y ago
I think the employees will probably be happy. The current market cap is above 5.5B. The 15% that is employee owned comes out to 825M. With 1100 employees, this comes out to an average of 750K per employee. Obviously this won't be distr
589.
by adenadel 11y ago
Interesting that (since 1971) of the 10% that have "left" the middle class, 7% have moved upward while 3% have moved downward.
590.
Transcriptic's “workcells”: fully automated labspace(transcriptic.com)
2 points by adenadel 11y ago|0 comments
591.
by adenadel 11y ago
There's no hard generational boundaries. For what it's worth: https://en.wikipedia.org/wiki/Millennials "Millennials are the demographic cohort following Generation X. There are no precise dates when the
592.
by adenadel 11y ago
The new website, https://verily.com/ , was down when I posted this.
593.
The missing piece to changing the university culture (2013)(nature.com)
1 points by adenadel 11y ago|0 comments
594.
by adenadel 11y ago
I want to clear up a misconception here. Odds are that for $100 you didn't get any sequencing done. More likely they used a genotyping chip to look for (potentially a lot) of specific variants. This is what 23andMe does. The price of s
595.
In Defense of Not-Invented-Here Syndrome (2001)(joelonsoftware.com)
2 points by adenadel 11y ago|0 comments
596.
What Can You Actually Do with Your Fancy Gene-Editing Technology?(theatlantic.com)
1 points by adenadel 11y ago|0 comments
597.
Regulators approve the first cancer-killing virus(nature.com)
1 points by adenadel 11y ago|0 comments
598.
Everything You Need to Know About CRISPR Gene Editing’s Monster Year(technologyreview.com)
2 points by adenadel 11y ago|0 comments
599.
Ubuntu hollywood [video](youtube.com)
1 points by adenadel 11y ago|0 comments
600.
Silicon rally: The changing US technology sector(economist.com)
1 points by adenadel 11y ago|0 comments

More ›